LC
AGTC

Lindbrook Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Lindbrook Capital’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-500
Closed -$2K – 1934
2020
Q1 		$2K Sell
500
-1,000
-67% -$5.27K ﹤0.01% 1354
2019
Q4 		$7K Buy
+1,500
New +$4.74K ﹤0.01% 1038

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Lindbrook Capital's AGTC Position: Q2 2020 in Review

Lindbrook Capital sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2020, closing a stake of 500 shares — an estimated $2K sold.

Lindbrook Capital first reported a position in AGTC in Q4 2019 and held it in 2 quarters. The position peaked at $7K in Q4 2019. 65 funds tracked by Wall St. Rank hold AGTC as of Q2 2020.

  • Lindbrook Capital reported no remaining Applied Genetic Technologies Corporation position as of Q2 2020 after selling out during the quarter.
  • Lindbrook Capital sold 500 Applied Genetic Technologies Corporation shares in Q2 2020, an estimated $2K.
  • Lindbrook Capital first reported a position in Applied Genetic Technologies Corporation in Q4 2019 and held it in 2 quarters.
  • Lindbrook Capital's Applied Genetic Technologies Corporation position peaked at $7K in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2020.

Based on Lindbrook Capital's 13F filing for Q2 2020, filed 27 Jul 2020.